SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor (OPEN) is trending due to a new COO hire from Shopify, sparking optimism for a turnaround and talk of a potential short squeeze. The community is actively discussing the stock's impressive gains, high short interest, and potential for further upside, while cautioning against FOMO. Some traders are pointing to a possible gamma squeeze, while others suggest an offering could be coming.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending following news of volume shipments of NVIDIA Blackwell Ultra solutions, sparking community discussion around the company's role in AI infrastructure.  Investors are weighing the potential for a gamma squeeze and debating the impact of the news amid existing short positions. The community is also discussing partnerships with companies like Oracle and Nokia.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending as investors discuss its AI strategy and potential impact on earnings, with the company set to report earnings. Community members are weighing the balance between new AI features and established competition, pondering whether a positive report can reverse the stock's recent struggles. Options traders anticipate significant movement, evidenced by elevated premiums.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

RH is trending following its earnings report and subsequent mixed reactions from the community, including a V-shape bounce in after-hours trading. While some investors express concern over missed revenue estimates and lowered guidance, others see potential in the company's expansion into Europe and potential benefits from future interest rate cuts. Community members are actively discussing possible price movements, with both bullish and bearish sentiments influencing the conversation.

MicroCloud Hologram, Inc. engages in research, development, and application of holographic technology. It operates through the Holographic Solutions and Holographic Technology Service segments. The company was founded in 2020 and is headquartered in New York, NY.

MicroCloud Hologram Inc

MicroCloud Hologram is trending amidst mixed sentiment, with some community members calling it a Chinese scam while others point to its potential in AI and crypto. The stock's low float and recent financial reports, including a reported profit, are being discussed, with some anticipating a squeeze while others remain skeptical due to the company's history and perceived lack of transparency.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's stock is trending amid discussions about its newly unveiled social platform and the introduction of short selling on its platform. The community is analyzing the potential impact of these developments on Robinhood's competitive position and user engagement, with some speculating about its effects on existing platforms like Stocktwits. Additionally, the stock's inclusion in the S&P 500 is adding to the conversation, with investors assessing its long-term growth prospects.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as the community discusses the potential for a short squeeze and buyout, fueled by increased volume and positive sentiment around their drug belapectin. Community members highlight the unmet need in late-stage cirrhosis and potential catalysts such as FDA feedback and partnership opportunities.  Recent discussions center around the significance of FDA accepting liver stiffness measurement as a surrogate endpoint.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid reports of a potential takeover bid from Paramount Skydance, sparking significant community discussion. Investors are weighing the implications of a possible cash-heavy offer and speculating about potential bidding wars, takeover prices, and the strategic rationale behind the deal given WBD's restructuring plans and valuable content library. Overall, the community seems excited about the potential for a buyout.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as investors react to mixed signals, including recent analyst ratings and news of executive stock sales. The community is weighing the potential impact of increased competition and the company's expansion into new areas like live sports and theme parks. Some traders are closely watching key technical levels, anticipating a potential breakout or breakdown.

Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. Its pipeline includes Dipraglurant, ADX71149, GABAB PAM, mGlu7 NAM, mGlu2 NAM, mGlu4 PAM, and mGlu3 PAM. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.

Addex Therapeutics Ltd - ADR

ADXN is trending due to a recent surge, fueled by community excitement around its potential as a low-float runner and a collaboration announcement, driving speculation of a continued breakout. Traders are actively discussing accumulation strategies, potential price targets, and the possibility of a short squeeze given the stock's limited public float. The community draws comparisons to other low-float stocks that have experienced significant gains, suggesting potential for substantial upward movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Misses Revenue Estimates

C4 Therapeutics (CCCC) delivered earnings and revenue surprises of +2.63% and -0.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Ocugen (OCGN) Reports Q2 Loss, Misses Revenue Estimates

Ocugen (OCGN) delivered earnings and revenue surprises of +16.67% and -1.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Tops Revenue Estimates

PureTech Founded Entity Seaport Therapeutics Names Lauren White as Chief Financial Officer

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, (Seaport) a...

Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), C4 Therapeutics (CCCC) and Lineage Therap (LCTX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Liquidia Technologies (LQDA Research Report), C4 Therapeutics...

Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults

Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults Biotech Sector Working to Combat Rising Cases of Colorectal Cancer in Young Adults PR Newswire VANCOUVER, BC, May...

Key Takeaways From C4 Therapeutics Analyst Ratings

Latest Ratings for CCCC
 DateFirmActionFromTo Mar 2022JP MorganInitiates Coverage OnOverweight Feb 2022Wells FargoInitiates Coverage OnEqual-Weight Nov 2021B of A SecuritiesInitiates Coverage OnBuy...

C4 Therapeutics, Inc. (NASDAQ:CCCC) Sees Significant Increase in Short Interest

C4 Therapeutics, Inc. (NASDAQ:CCCC  Get Free Report) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 5,290,000 shares, a growth of...

C4 Therapeutics (NASDAQ:CCCC) Trading Down 3.9%

Shares of C4 Therapeutics, Inc. (NASDAQ:CCCC  Get Free Report) dropped 3.9% during mid-day trading on Wednesday . The company traded as low as $8.35 and last traded at $8.35. Approximately...

C4 Therapeutics (NASDAQ:CCCC)  Shares Down 6.8%

C4 Therapeutics, Inc. (NASDAQ:CCCC  Get Free Report) shares dropped 6.8% during trading on Thursday . The company traded as low as $9.92 and last traded at $10.00. Approximately 560,028 shares...

C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in October 2015 and is headquartered in Watertown, MA.

C4 Therapeutics Inc

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with $OPEN stock after the major announcements last night?

Stocktwits

 stock after the major announcements last night?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.40	--	--	N/A
Q2 '25	-$0.38	-$0.37	3.65%	BEAT
Q1 '25	-$0.44	-$0.37	16.29%	BEAT
Q4 '24	-$0.49	-$0.49	0.62%	BEAT
Q3 '24	-$0.38	-$0.35	7.64%	BEAT

CCCC
C4 Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest CCCC News

CCCC C4 Therapeutics Inc